Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC

01.04.25 14:00 Uhr

Werte in diesem Artikel
Aktien

306,90 EUR -13,00 EUR -4,06%

News Summary

  • Boosts out-of-the-box sensitivity by up to 80 times with MaxPeakTM Premier columns.1
  • Delivers over threefold improvements in day-to-day reproducibility2 and decreases carryover by up to two orders of magnitude.3
  • Reduces common user errors by up to 40%.4

MILFORD, Mass., April 1, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the expansion of the Alliance™ iS Bio HPLC product line with integrated photodiode array (PDA) detection, advancing the capabilities of the next-generation intelligent HPLC platform designed for development and Quality Control (QC) laboratories.

The new Waters Alliance iS Bio HPLC System with integrated PDA Detector combines advanced bioseparation technology with built-in instrument intelligence to enhance flexibility, operational efficiency, performance, and ease of use in biopharma quality control (QC) laboratories

Enhances out-of-the-box sensitivity by up to 80 times compared to traditional systems and columns.

"The addition of the Alliance iS Bio HPLC System with PDA detection allows biopharmaceutical laboratories to perform enhanced spectral analysis, including impurity detection, peak purity analysis, multi-wavelength detection, and method validation, to deliver safe and effective products," said Fraser McLeod, Vice President, General Manager, QA/QC, at Waters Corporation. "Built on the Alliance iS HPLC Platform, the system is designed to simplify the analysis of complex biopharmaceuticals in development and QC, reduce errors, and improve accuracy and operational efficiency."

The Alliance iS HPLC Platform has been purposefully designed to simplify laboratory workflows by reducing the risk of out-of-specification results and the need for troubleshooting. Default system parameters provide over threefold improvement in day-to-day reproducibility2 and reduce carryover by up to two orders of magnitude,3 compared to other systems on the market. Additionally, with MaxPeak Premier columns, the Alliance iS Bio HPLC System enhances out-of-the-box sensitivity by up to 80 times compared to traditional systems and columns.1  

Waters now offers four configurations of the Alliance iS HPLC Platform to support routine quantitative analysis and expanded spectral analysis of small and large molecules in development and QC. All configurations are controlled by the compliance-ready Waters EmpowerTM Chromatography Data System, which enables laboratories to collect, manage, and report chromatography test results. The platform also supports connectivity with laboratory information management systems (LIMS) to help high-volume QC labs manage operational risk, mitigate disruptions, and increase overall productivity.

The Alliance iS HPLC Platform has earned the Accountability, Consistency, and Transparency (ACT) Ecolabels from My Green Lab, a nonprofit organization dedicated to building a global culture of sustainability in science. Notably, the product line was recognized for its sustainable manufacturing practices and innovative error-reducing design, underscoring the commitment of Waters to reducing the most significant environmental impacts.

The Waters Alliance iS Bio HPLC System with PDA detection is available for order now.

Additional Resources:

Waters, Alliance, MaxPeak, and Empower are trademarks of Waters Technologies Corporation.

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of food and the purity of water, and the quality and sustainability of products used every day. In over 100 countries, our 7,600+ passionate employees collaborate with customers in laboratories, manufacturing sites, and hospitals to accelerate the benefits of pioneering science.

Contact:
Janice Foley
Senior Public Relations Manager, Corporate Communications
Waters Corporation
janice_foley@waters.com
Mobile: +1.617.823.5555

1. Application Note: Mitigation of Non-Specific Adsorption During Column Conditioning for an Oligonucleotide HILIC Analysis | Waters. In a well-controlled experiment, oligonucleotides were analyzed with a HILIC application to compare method performance with stainless steel systems and columns with MaxPeak HPS solutions. Percent recovery was tracked for all possible configurations without system passivation and the system configuration with a MaxPeak HPS column and Alliance iS Bio System outperformed other configurations with 80x greater sensitivity than an all-stainless-steel configurations (Figure 10).

2. Application Note: HPLC Autosampler Performance II: Improved Injection Precision of USP Methods With the Alliance™ iS HPLC System. In multiple well-controlled experiments with a range of analytes and diluents, injection precision was highest on the Alliance iS HPLC system compared to other HPLC systems on the market.


3. Application Note: Improved chlorhexidine carryover performance using the Alliance iS HPLC System. In a well-controlled experiment, chlorhexidine carryover was measured to be 0.00055% on the Alliance iS HPLC System and up to 0.05% for other HPLC systems on the market.


4. Based on Waters market research in 2022, surveying 56 global Pharma QC labs running >25 systems.


Waters Corporation (PRNewsfoto/Waters Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/waters-expands-alliance-is-bio-hplc-product-line-with-photodiode-array-detector-to-enhance-spectral-insights-for-biopharma-development--qc-302416120.html

SOURCE Waters Corporation

In eigener Sache

Übrigens: Waters und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Waters

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Waters

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Waters Corp.

Wer­bung

Analysen zu Waters Corp.

DatumRatingAnalyst
30.05.2019Waters UnderperformWolfe Research
03.01.2019Waters HoldNeedham & Company, LLC
09.10.2018Waters NeutralUBS AG
24.01.2018Waters Equal WeightBarclays Capital
05.01.2018Waters BuyBTIG Research
DatumRatingAnalyst
05.01.2018Waters BuyBTIG Research
18.01.2017Waters BuyDeutsche Bank AG
25.10.2016Waters BuyCantor Fitzgerald
29.04.2015Waters BuyMaxim Group
28.10.2011Waters outperformRBC Capital Markets
DatumRatingAnalyst
03.01.2019Waters HoldNeedham & Company, LLC
09.10.2018Waters NeutralUBS AG
24.01.2018Waters Equal WeightBarclays Capital
27.04.2016Waters NeutralMizuho
01.03.2016Waters Equal WeightBarclays Capital
DatumRatingAnalyst
30.05.2019Waters UnderperformWolfe Research

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Waters Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen